Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia.
Garcia-Gisbert N, Arenillas L, Roman-Bravo D, Rodriguez-Sevilla JJ, Fernández-Rodríguez C, Garcia-Avila S, Velez P, Gibert J, Fernández-Ibarrondo L, Salar A, Florensa L, Bellosillo B, Ferrer A, Calvo X. Garcia-Gisbert N, et al. Among authors: roman bravo d. Leukemia. 2022 Dec;36(12):2922-2926. doi: 10.1038/s41375-022-01733-8. Epub 2022 Oct 22. Leukemia. 2022. PMID: 36273104 No abstract available.
Sex-associated differences in genomic profile of chronic myelomonocytic leukemia involving differential representation of SRSF2 gene mutation.
Calvo X, Roman-Bravo D, Garcia-Gisbert N, Fernández-Rodríguez C, Rial-Villavecchia A, Garcia-Avila S, López-Cadenas F, Salido M, Ferrer Del Álamo A, Arenillas L. Calvo X, et al. Among authors: roman bravo d. Int J Lab Hematol. 2023 Dec;45(6):1011-1015. doi: 10.1111/ijlh.14141. Epub 2023 Aug 3. Int J Lab Hematol. 2023. PMID: 37536950 No abstract available.
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.
Calvo X, Roman-Bravo D, Garcia-Gisbert N, Rodriguez-Sevilla JJ, Garcia-Avila S, Florensa L, Gibert J, Fernández-Rodríguez C, Salido M, Puiggros A, Espinet B, Colomo L, Bellosillo B, Ferrer A, Arenillas L. Calvo X, et al. Among authors: roman bravo d. Blood Adv. 2022 Jul 12;6(13):3921-3931. doi: 10.1182/bloodadvances.2022007359. Blood Adv. 2022. PMID: 35709473 Free PMC article.
Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features.
Calvo X, Garcia-Gisbert N, Parraga I, Gibert J, Florensa L, Andrade-Campos M, Merchan B, Garcia-Avila S, Montesdeoca S, Fernández-Rodríguez C, Salido M, Puiggros A, Espinet B, Colomo L, Roman-Bravo D, Bellosillo B, Ferrer A, Arenillas L. Calvo X, et al. Among authors: roman bravo d. Blood Adv. 2020 Oct 27;4(20):5285-5296. doi: 10.1182/bloodadvances.2020002206. Blood Adv. 2020. PMID: 33108455 Free PMC article.